GSK Invests $300M in Next-Generation Lupus Drug from Chimagen Biosciences
Building on its legacy as a leader in lupus treatment, GlaxoSmithKline (GSK) is making a substantial investment in a new ...
Building on its legacy as a leader in lupus treatment, GlaxoSmithKline (GSK) is making a substantial investment in a new ...
© 2020 The Lagos Today - Nkali.